© Siemens

Siemens Healthineers reported a decline on a comparable basis of five percentage points to €5.601 billion (Q1/2023: €6.087 billion). The book-to-bill ratio was above 1. Earnings and profitability improved as a result of higher revenue and cost reductions in the Diagnostics business in connection with its transformation program.